AngioDynamics, Inc. (ANGO) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 5 Buy, 6 Hold.
The consensus price target is $16.50 (low: $12.00, high: $22.00), representing an upside of 57.6% from the current price $10.47.
Analysts estimate Earnings Per Share (EPS) of $-0.52 and revenue of $0.27B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-4.59 vs est $-0.52 (missed -788.4%). 2025: actual $-0.83 vs est $-0.28 (missed -199.6%). Analyst accuracy: 22%.
ANGO Stock — 12-Month Price Forecast
$16.50
▲ +57.59% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for AngioDynamics, Inc., the average price target is $16.50, with a high forecast of $22.00, and a low forecast of $12.00.
The average price target represents a +57.59% change from the last price of $10.47.
Highest Price Target
$22.00
Average Price Target
$16.50
Lowest Price Target
$12.00
ANGO Analyst Ratings
Hold
Based on 11 analysts giving stock ratings to AngioDynamics, Inc. in the past 3 months
EPS Estimates — ANGO
22%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$4.59
vs Est –$0.52
▼ 88.7% off
2025
Actual –$0.83
vs Est –$0.28
▼ 66.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — ANGO
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.304B
vs Est $0.271B
▲ 11.0% off
2025
Actual $0.292B
vs Est $0.287B
▲ 2.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
